-
Signature
-
/s/ Jeffrey J. Plumer, as attorney-in-fact for Rui Avelar
-
Stock symbol
-
EOLS
-
Transactions as of
-
Jan 25, 2023
-
Transactions value $
-
$0
-
Form type
-
4
-
Date filed
-
1/27/2023, 06:25 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
EOLS |
Common Stock |
Award |
$0 |
+97.6K |
+38.56% |
$0.00 |
351K |
Jan 25, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
EOLS |
Stock Option (Right to Buy) |
Award |
$0 |
+85.7K |
|
$0.00 |
85.7K |
Jan 25, 2023 |
Common Stock |
85.7K |
$11.04 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Chief Medical Officer and Head of Research & Development